CDKN1B and ovarian carcinoma: Interestingly, flutamide did not prevent DHT-induced p27 degradation, and other androgens, including testosterone and DHEA, failed to affect p27 expression/degradation [87], suggesting that DHT modulates the cell cycle progression of ovarian cancer not via the traditional AR pathway.